[MDGL] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
03-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -15.65%
YoY- -31.06%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -85,800 -76,896 -85,905 -81,197 -70,730 -57,518 -64,549 20.95%
Tax 3,425 896 1,682 1,502 780 69 -106 -
NP -85,800 -77,792 -87,587 -82,699 -71,510 -57,587 -64,549 20.95%
Tax Rate - - - - - - - -
Total Cost 85,800 77,792 87,587 82,699 71,510 57,587 64,549 20.95%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -4.69 -4.28 -5.08 -4.84 -4.18 -3.37 -3.78 15.51%
EPS Diluted -4.69 -4.28 -5.08 -4.84 -4.18 -3.37 -3.78 15.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.